Indications
Therapeutic Asset Ratings
5,098 results matching 1 filter
91,565
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Adriamycin
Ovarian Serous Tumor
National Cancer Institute (NCI)
P3
B
(60)
Afuresertib
Breast Cancer
Laekna Limited
P3
B
(60)
ak112
Non-Small Cell Lung Carcinoma
Akeso
P3
B
(60)
Alectinib
ALK-Positive Anaplastic Large Cell Lymphoma
Nuvalent Inc.
P3
B
(60)
All-P-Ambo-(5'?3')-[2?-O-(2-Methylamino)-2-Oxoethyl]-P-Thiocytidylyl-(5'?3')-[2?-O-(2-Methylamino)-2-Oxoethyl]Adenylyl-(5'?3')-[2?-O-(2-Methylamino)-2-Oxoethyl]-P-Thio[(5-Methyl)Cytidylyl)]-(5'?3')-[2?-O-(2-Methylamino)-2-Oxoethyl]-[(5-Methyl)Uridylyl-)]-(5'?3')-[2?-O-(2-Methylamino)-2-Oxoethyl]-P-Thio[(5-Methyl)Uridylyl)]-(5'?3')-[2?-O-(2-Methylamino)-2-Oxoethyl]-P-Thio[(5-Methyl)Uridylyl)]-(5'?3')-[2?-O-(2-Methylamino)-2-Oxoethyl]-P-Thio[(5-Methyl)Cytidylyl)]-(5'?3')-[2?-O-(2-Methylamino)-2-Oxoethyl]-P-Thioadenylyl)]-(5'?3')-[2?-O-(2-Methylamino)-2-Oxoethyl]-P-Thio[(5-Methyl)Uridylyl)]-(5'?3')-[2?-O-(2-Methylamino)-2-Oxoethyl]-P-Thioadenylyl)]-(5'?3')-[2?-O-(2-Methylamino)-2-Oxoethyl]-P-Thioadenylyl)]-(5'?3')-[2?-O-(2-Methylamino)-2-Oxoethyl]-P-Thio[(5-Methyl)Uridylyl)]-(5'?3')-[2?-O-(2-Methylamino)-2-Oxoethyl]-P-Thioguanylyl)]-(5'?3')-[2?-O-(2-Methylamino)-2-Oxoethyl]-P-Thio[(5-Methyl)Cytidylyl)]-(5'?3')-[2?-O-(2-Methylamino)-2-Oxoethyl]-P-Thio[(5-Methyl)Uridylyl)]-(5'?3')-[2?-O-(2-Methylamino)-2-Oxoethyl]-P-Thioguanylyl)]-(5'?3')-[2?-O-(2-Methylamino)-2-Oxoethyl]-P-Thioguanylyl)]-(5-Methyl)Cytidine
Spinal Muscular Atrophy
Biogen
P3
B
(60)
Aln-Ttrsc02
Familial Amyloid Neuropathy
Alnylam Pharmaceuticals
P3
B
(60)
Aloradine
Social Phobia
VistaGen Therapeutics, Inc.
P3
B
(60)
.Alpha.-1 Protease Inhibitor
Emphysema, Hereditary Pulmonary
Grifols Therapeutics LLC
P3
B
(60)
Amitriptyline
Interstitial Cystitis
Jocelyn Fitzgerald
P3
B
(60)
Amitriptyline
Levator Syndrome
Jocelyn Fitzgerald
P3
B
(60)
Amlodipine
Cognitive Disorder
Hospital Moinhos de Vento
P3
B
(60)
Amoxicillin
Musculoskeletal System Disorder
Bart Koes
P3
B
(60)
Anakinra
Febrile Infection-Related Epilepsy Syndrome
Yale University
P3
B
(60)
Anastrozole
Breast Adenocarcinoma
National Cancer Institute (NCI)
P3
B
(60)
Anastrozole
Lobular Breast Carcinoma In Situ
Alliance for Clinical Trials in Oncology
P3
B
(60)
Anastrozole
Invasive Ductal Breast Carcinoma
Alliance for Clinical Trials in Oncology
P3
B
(60)
Anastrozole
Invasive Lobular Breast Carcinoma
Alliance for Clinical Trials in Oncology
P3
B
(60)
Anastrozole
Klinefelter Syndrome
Georgios Papadakis
P3
B
(60)
Anastrozole
Ovarian Serous Adenocarcinoma
Verastem, Inc.
P3
B
(60)
Anastrozole
Synchronous Bilateral Breast Carcinoma
National Cancer Institute (NCI)
P3
B
(60)
Anbenitamab
HER2 Positive Breast Carcinoma
Shanghai JMT-Bio Inc.
P3
B
(60)
Anisodine Hydrobromide
Migraine Without Aura
Second Affiliated Hospital, School of Medicine, Zhejiang University
P3
B
(60)
Anlotinib Hydrochloride Capsules
Hepatocellular Carcinoma
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
P3
B
(60)
Anlotinib Hydrochloride Capsules
Ovarian Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
P3
B
(60)
Anselamimab
AL Amyloidosis
Alexion Pharmaceuticals, Inc.
P3
B
(60)
Showing 2751 to 2775 of 5,098 assets
Previous
Page 111 of 204
Next